Discovery of novel falcipain 2 inhibitors by in silico guided drug repositioning | ||
| dc.conicet.organizacion | Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres" | |
| dc.conicet.organizacion | Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús). Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús) | |
| dc.conicet.organizacion | Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.rol | Autor | |
| dc.conicet.rol | Autor | |
| dc.conicet.rol | Autor | |
| dc.conicet.rol | Autor | |
| dc.conicet.rol | Autor | |
| dc.contributor.author | Alberca, Lucas Nicolás | |
| dc.contributor.author | Chuguransky, Sara Rocío | |
| dc.contributor.author | Alvarez, Cora Lilia | |
| dc.contributor.author | Salas Sarduy, Emir | |
| dc.contributor.author | Talevi, Alan | |
| dc.coverage | Internacional | |
| dc.date.evento | 2019-05-12 | |
| dc.date.eventoHasta | 2019-05-15 | |
| dc.date.issued | 2019 | es |
| dc.description.abstract | Malaria is a life-threatening condition that continues being one of global leading causes of death worldwide, being themain cause of death globally in the 5-14 year-old population. The disease is caused by parasites from the Plasmodiumgenre. The emergence of Plasmodium falciparum resistant strains with reduced sensitivity to the first linecombination therapy have led to renewed interest in novel therapeutic options. In this work, our objective was theidentification of novel Falcipan-2 (FP2) inhibitors through the application of an in silico approach and the subsequentin vitro evaluation of the emerging hits. FP2 is a key cysteine protease in the life cycle of P. falciparum constituting apromising target in the search for novel therapies due to their significant hemoglobinase capacity.We have developed a ligand-based model ensemble capable of recognizing FP2 inhibitors from non-inhibitors. Thisensemble has showed a powerful ability for the identification of FP2 inhibitors. The ensemble was applied in a virtualscreening campaign of DrugBank database to identify approved drugs with FP2 inhibitory activity. 4 hits wereacquired and tested against recombinant FP2 using a fluorogenic continuous enzymatic assay under balanced assayconditions ([S]0/KM=1). The reversibility of the interaction, mode of inhibition and Ki were further investigated forvalidated hits. Two drugs, Methacycline and Odanacatib, showed dose-dependent inhibition of FP2. Although bothinhibitors showed reversible interactions with FP2, the compounds displayed different inhibition mechanisms. Doseresponseanalysis at growing substrate concentrations indicated that Odanacatib is a competitive inhibitor of FP2(Ki=98.2 nM), whereas Methacycline displayed non-competitive behaviour (Ki=84.4 μM; α =1.42) being to our bestknowledge the first report of the inhibition of plasmodial cysteine proteases by a tetracycline derivative in a noncompetitivemanner. To access the impact of Methacycline and Odanacatib on the intracellular parasite?sdevelopment, parasite trophozoite forms were treated with the compounds for 48h and the parasitemia was analyzedby light microscopy. Treatment of infected erythrocytes with the compounds caused inhibition in a dose-dependentmanner. These results demonstrate the utility of the in silico approach, since we could find two FP2 inhibitors withantiplasmodial activity with a minimal investment of time and money. | es |
| dc.description.ciudadEvento | Dundee | es |
| dc.description.fil | Fil: Alberca, Lucas Nicolás. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina | |
| dc.description.fil | Fil: Chuguransky, Sara Rocío. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Alvarez, Cora Lilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina | |
| dc.description.fil | Fil: Salas Sarduy, Emir. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús). Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús); Argentina | |
| dc.description.fil | Fil: Talevi, Alan. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.institucionOrganizadora | Centre for Anti-Infectives Research | es |
| dc.description.institucionOrganizadora | University of Dundee | es |
| dc.description.nombreEvento | Conference on drug discovery & development | es |
| dc.description.paisEvento | Reino Unido | es |
| dc.format | application/pdf | es |
| dc.identifier.citation | Discovery of novel falcipain 2 inhibitors by in silico guided drug repositioning; Conference on drug discovery & development; Dundee; Reino Unido; 2019; 1-1 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/153829 | |
| dc.journal.ciudad | Dundee | es |
| dc.journal.pagination | 1-1 | es |
| dc.journal.pais | Reino Unido | es |
| dc.language.iso | eng | es |
| dc.publisher | University of Dundee | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://d1ssu070pg2v9i.cloudfront.net/pex/wcair/2019/05/07112934/SOSID-Programme-and-Abstract-book_digital.pdf | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://wcair.dundee.ac.uk/events/setting-our-sights-on-infectious-diseases/ | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.source.libro | Setting our sights on infectious diseases | es |
| dc.subject | MALARIA | es |
| dc.subject | PLASMODIUM FALCIPARUM | es |
| dc.subject | FALCIPAIN 2 | es |
| dc.subject | VIRTUAL SCREENING | es |
| dc.subject.classification | Otras Ciencias Químicas | es |
| dc.subject.classification | Ciencias Químicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Discovery of novel falcipain 2 inhibitors by in silico guided drug repositioning | es |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | info:eu-repo/semantics/conferenceObject | |
| dc.type | info:ar-repo/semantics/documento de conferencia | |
| dc.type.publicacion | Book | es |
| dc.type.subtype | Conferencia | es |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.d55fb463-5d33-4b6f-8b82-6a2e3178dc26_B.pdf
- Tamaño:
- 326.75 KB
- Formato:
- Adobe Portable Document Format
- Descripción: